Panbela Therapeutics News

Panbela Therapeutics | DEFA14A: Others

Apr 25 16:42 ET

Panbela Therapeutics | 8-K: Current report

Apr 25 16:41 ET

Panbela Therapeutics | 25-NSE: Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities (and amendment thereto)

Apr 25 09:15 ET

Panbela Therapeutics | 8-K: Current report

Apr 22 08:05 ET

Panbela Therapeutics | S-1: General form for registration of securities under the Securities Act of 1933

Apr 18 16:33 ET

Panbela Therapeutics | 8-K: Current report

Apr 17 08:39 ET

Panbela Therapeutics | EFFECT: Others

Apr 17 06:10 ET

Panbela Therapeutics | DEF 14A: Definitive information statements

Apr 4 16:22 ET

Panbela Therapeutics | EFFECT: Others

Apr 3 06:07 ET

Panbela Therapeutics | S-1: General form for registration of securities under the Securities Act of 1933

Mar 29 17:28 ET

Panbela Therapeutics | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing

Mar 29 17:13 ET

Panbela Therapeutics | 10-K: Annual report

Mar 26 16:20 ET

Panbela Therapeutics | 8-K: Current report

Mar 26 16:16 ET

Panbela Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Mar 25 16:22 ET

Panbela Therapeutics | 8-K: Current report

Mar 7 06:05 ET

Panbela Therapeutics | 8-K: Current report

Feb 15 08:07 ET

Panbela Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Lind Global Fund II LP(0%),Lind Global Partners II LLC(0%), etc.

Feb 13 20:16 ET

Panbela Therapeutics | 8-K: Current report

Feb 13 17:35 ET

Panbela Therapeutics | 8-K: Current report

Feb 1 07:16 ET

Panbela Therapeutics | 424B4: Prospectus

Jan 30 17:33 ET